NextCure Inc. has announced a one-for-twelve reverse stock split of its common stock, effective July 14, 2025. The stockholders approved an amendment enabling a reverse stock split at a ratio between one-to-five and one-to-fifteen, with the board of directors deciding on the final ratio. No fractional shares will be issued; instead, stockholders will receive cash for any fractional shares based on the closing price before the split. The common stock will trade on a split-adjusted basis on the Nasdaq Global Select Market under the ticker symbol "NXTC".
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。